Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer

BACKGROUND: In early trials, hypersensitivity reactions (HSRs) to paclitaxel were common, thus prompting the administration of antihistamines and corticosteroids before every paclitaxel dose. We tested the safety of omitting corticosteroids after cycle 2 during the paclitaxel portion of the dose‐den...

Descripción completa

Detalles Bibliográficos
Autores principales: Barroso‐Sousa, Romualdo, Vaz‐Luis, Ines, Di Meglio, Antonio, Hu, Jiani, Li, Tianyu, Rees, Rebecca, Sinclair, Natalie, Milisits, Lindsey, Leone, Jose Pablo, Constantine, Michael, Faggen, Meredith, Briccetti, Frederick, Block, Caroline, Partridge, Ann, Burstein, Harold, Waks, Adrienne G., Tayob, Nabihah, Trippa, Lorenzo, Tolaney, Sara M., Hassett, Michael J., Winer, Eric P., Lin, Nancy U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571744/
https://www.ncbi.nlm.nih.gov/pubmed/34472667
http://dx.doi.org/10.1002/onco.13960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571744/
https://www.ncbi.nlm.nih.gov/pubmed/34472667
http://dx.doi.org/10.1002/onco.13960

Ejemplares similares